Successful use of the potent enzyme inducer enzalutamide in a treatment-experienced HIV-positive male with prostate cancer.
AIDS. 2018 Nov 13;32(17):2640-2642
Therapeutic drug monitoring in treatment-experienced HIV-infected patients receiving darunavir-based salvage regimens: A case series.
Antiviral Res. 2018 Feb 16;:
Sensors (Basel). 2017 Jul 16;17(7):
Ann Pharmacother. 2017 Jun 01;:1060028017717018
Increase in international normalized ratio after switching from atazanavir/ritonavir to darunavir/cobicistat in a patient on warfarin: boosters are not always equal.
AIDS. 2017 Jan 02;31(1):175-176
CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core Research Group: 2016 Updated Canadian HIV/Hepatitis C Adult Guidelines for Management and Treatment.
Can J Infect Dis Med Microbiol. 2016;2016:4385643
Mutant IDH1 Downregulates ATM and Alters DNA Repair and Sensitivity to DNA Damage Independent of TET2.
Cancer Cell. 2016 Jul 9;
Drug interactions between antiretrovirals and drugs used to treat benign prostatic hypertrophy/lower urinary tract symptoms.
Expert Opin Drug Metab Toxicol. 2016 Jul 4;
Hepatotoxicity and Potential Drug Interaction with Ledipasvir/Sofosbuvir In HIV/HCV Infected Patients.
J Hepatol. 2016 May 19;
J Acquir Immune Defic Syndr. 2016 Jun 1;72(2):153-61